KingMed Diagnostics
4
30M
4
0.14
2
- Stages of investment
- Areas of investment
Summary
In 1994 was created KingMed Diagnostics, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Guangzhou. The venture was found in Asia in China.
The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AnchorDx. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are Emergency Medicine, Pharmaceutical.
The typical case for the fund is to invest in rounds with 4 participants. Despite the KingMed Diagnostics, startups are often financed by Northern Light Venture Capital, Marathon Venture Partners. The meaningful sponsors for the fund in investment in the same round are WuXi AppTec, Sijia Jianxin Fund, Marathon Venture Partners.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 2
- Rounds per year
- 0.14
- Investments by industry
- Biotechnology (3)
- Genetics (2)
- Emergency Medicine (1)
- Pharmaceutical (1)
- Enterprise (1) Show 1 more
- Investments by region
-
- China (4)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| GeneMind Biosciences | 02 Aug 2023 | Biotechnology, Genetics, Life Science | Late Stage Venture | 61M | Guangdong, Jiangxi, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.